Testing a new treatment for symptomatic paroxysmal atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new device, the Globe® Pulsed Field System, to treat people with paroxysmal atrial fibrillation (AFib) that comes and goes and causes symptoms, especially if standard medications haven't worked or caused side effects. It's designed to see if this system is a safe and effective option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have paroxysmal AFib that comes and goes and causes symptoms
- You've tried at least one heart rhythm medication (like flecainide or sotalol) that didn't work or you couldn't tolerate
- You don't have AFib that's constant or lasts longer than 12 months
- You haven't had a blood clot, stroke, heart attack, heart surgery, or a catheter ablation in your heart's upper chambers within the last 3 to 6 months
- Your body mass index (BMI) is 40 or less, and your heart's pumping ability and left atrial size are within a certain range
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if this approach is safe and effective for people with AF that comes and goes or lasts for a short time.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This study follows patients who are already scheduled to receive a specific heart rhythm treatment called Globe pulsed field ablation for atrial fibrillation (an irregular heartbeat condition). Researchers will track how well the procedure works and how patients do afterward.
This trial tests a new catheter and mapping system designed to treat paroxysmal atrial fibrillation (AF), which is a type of irregular heartbeat that comes and goes. If you have this condition, the study aims to see how well the new system works with a minimally invasive procedure.
This trial tests a new type of heart procedure that uses gentle electrical pulses to fix abnormal signals in the upper chambers of the heart for people with a specific type of atrial fibrillation that comes and goes on its own. It may be an option if your AFib episodes stop within 7 days and medications haven't helped enough.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.